BioTrinity 2012 Participants

BioTrinity 2012 will bring together investors, global phama and innovative biotech and medtech R&D companies under one roof.  With over 475 companies already confirmed with just a few days to go, and 800 delegates already registered from 26 countries, including over 70 investment firms and individual investors, BioTrinity 2012 is set to beat our previous record attendance (expect 800+ delegates), maintaining BioTrinity again as an ever-expanding well organized and unique offering of valuable investor and pharma partnering opportunities. Take a look at the list of companies confirmed below.

Corporate venturers and senior licensing / business development execs from Abbott, Amgen, Astellas, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Eli Lilly, Genzyme, Goldshield Group, GSK, Merck, Novartis, Pfizer, Shire, Takeda, Teva, MedImmune Ventures, SR One, Shire Strategic Investment Group, Merck Serono Ventures, Merck Research Venture Fund, Abbott Biotech Ventures , Astellas Venture Management, and Boehringer Ingelheim Venture Fund are confirmed as attending in 2012.

In 2011 more than 750 delegates from 450 participant companies from 20 countries onboard, making BioTrinity once again the largest gathering of the UK bioindustry, and 3rd largest biopartnering conference in Europe. Investment firms constituted nearly one fifth of the conference participants.  Whereas professional services firms will consitute less than one tenth of organisations represented at BioTrinity 2012, as a result of this year's changes to registration terms giving preference to R&D companies.

Read the testimonials received from delegates from previous years to find out what other delegates say...

See who's attending in 2012:

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M  |  N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

 

  • 3i Group
  • 3M Drug Delivery Systems
  • A4P Bioanalytical Consulting
  • Aché Laboratórios Farmacêuticos (Brazil)
  • Abbott
  • Abbott Biotech Ventures (USA)
  • Abbott Laboratories
  • AbD Serotec
  • Abgent Europe 
  • Abingworth LLP
  • Absynth Biologics 
  • Accent Gründerservice GmbH (Austria)
  • Adaptimmune
  • AdvantageAustria (Austria)
  • Advocates Pharmaceutical & Healthcare
  • Advent Venture Partners
  • Aescap Venture (Netherlands)
  • Alacrita Consulting
  • Albion Income and Growth VCT plc
  • Albion Ventures LLP
  • Alchemy PharmaTech
  • Algeta ASA (Norway)
  • Almac
  • Almac Discovery 
  • Amgen
  • Amakem Therapeutics
  • AMRI
  • AMSBIO
  • AnaBioTec (Belgium)
  • Anachem
  • Angel Biotechnology
  • Angita Pharmaceuticals (Netherlands)
  • Antoxis
  • Apex Healthcare Consulting
  • Apollo Consultancy
  • Applied Integrin Sciences, Inc. (United States)
  • Apposite Capital
  • Aptiv Solutions (United States)
  • Aptuit
  • Aquarius Equity Partners
  • Ardington Archives
  • Argenta Discovery
  • arGEN-X BV (Netherlands)
  • Aston University - Business Partnership Unit
  • Astellas Pharma Europe
  • Astellas Venture Management
  • AstraZeneca
  • Atlas Venture, Inc. (USA)
  • ATPBio Ltd
  • Austrian Business Agency
  • Austrian Trade Commission
  • Avienne Pharmaceuticals GmbH (Austria)
  • Axis Shield plc
  • Babraham Bioscience Technologies
  • Baker Botts (UK) LLP
  • BBInternational and BBI Enzymes
  • BBSRC
  • Beer and Partners
  • Berkley PLS UK
  • BigBear Communications
  • BioCity Nottingham
  • BigDNA
  • Bio2Business Ltd   
  • BioDundee
  • BioFIT (Fostering Innovation&Transfer) (France)
  • BioFocus
  • BioFutur (media, France)
  • Biogen Idec (Switzerland)
  • Biognosys AG (Switzerland)
  • Biolty, S.L. (Spain)
  • Bionext (France)
  • Bionure Farma, S.L (Spain)
  • BioPark
  • BioPharm Insight
  • Biotech Personnel
  • Biotec Services International
  • Bioventix plc
  • BioVex/Amgen
  • Black Swan Analysis 
  • Bloomberg News
  • Boehringer Ingelheim Venture Fund
  • BRAINco BioPharma (Spain)
  • Bristol-Myers Squibb 
  • British Heart Foundation
  • BruCells (Belgium)
  • Cambridge Cognition
  • Cambridge Consultants
  • Cambridge Healthcare & Biotech
  • Carbogen Amcis AG (Switzerland)
  • Cardeus Pharmaceuticals, Inc. (USA)
  • cddi 
  • Celerion
  • Celtic Pharma Holdings Advisors LLP
  • Charles River BPS
  • ChemPartner Europe (Denmark)
  • Chempetitive Group
  • Chroma Therapeutics
  • Circassia
  • Citeline
  • Citigate Dewe Rogerson
  • Clubb Capital
  • CMS Cameron McKenna
  • Cobra Biologics Prokarium
  • Cole Palmer
  • College Hill Life Sciences
  • CollerIP
  • Colworth Science Park
  • Confluence Tax LLP
  • Convergence Pharmaceuticals 
  • Covington & Burling LLP
  • Creabilis-SA (Luxembourg)
  • Crédit Agricole Private Equity (France)
  • Crescent Diagnostics (Ireland)
  • Critical Pharmaceuticals
  • CSL Recruitment
  • CTPartners
  • Cyclofluidic 
  • Cyclogenix 
  • Cyprotex Discovery 
  • Cytox
  • D2L Pharma Research Solutions pvt. (India)
  • Dando,Weiss & Colucci
  • Data Magik 
  • Datamonitor
  • Debiopharm SA (Switzerland)
  • Dehns
  • deltaDOT
  • Delta Partners (Ireland)
  • Dilafor AB (Sweden)
  • Doctors net uk
  • Domainex
  • Dr Reddy's
  • Drug Discovery Today
  • EBD Group
  • ECI Partners
  • Edinburgh BioQuarter
  • Edmond de Rothschild Investment Partners (France)
  • Edwards Wildman Palmer UK LLP
  • Elasmogen
  • Eli Lilly
  • Elsevier Business Intelligence
  • Elsevier Information Systems GmbH (Germany)
  • Emball'iso
  • Enkam Pharmaceuticals (Denmark)
  • Entrepreneurs Fund Management LLP
  • Enzymatics Inc. (USA)
  • Epistem plc
  • EP Vantage
  • ERA Consulting (UK) 
  • Ernst & Young
  • Esperante Ventures (Netherlands)
  • Essen BioScience Ltd (USA)
  • e-Therapeutics plc
  • EUCODIS Bioscience (Austria)
  • Eurasia Gmbh (Austria)
  • Eurogentec
  • Exova Pharma
  • Fasken Martineau LLP
  • FGK Clinical Research GmbH (Germany)
  • FibroMed
  • Finance Wales
  • FINOX Biotech (Switzerland)
  • Fisher Scientific
  • Future Injection Technologies
  • FOCUS Insurance
  • Forbion Capital Partners (Netherlands)
  • Forresters
  • Fountain Healthcare Partners (Ireland)
  • Fry Heath and Spence
  • f-star GmbH (Austria)
  • Fujifilm Diosynth Biotechnologies
  • Galapagos (Netherlands)
  • Gallus BioPharmaceuticals (US)
  • Genetrix SL (Spain)
  • Gen-Probe Life Sciences
  • Genzyme (a Sanofi company)
  • george james ltd
  • GFA
  • GlaxoSmithKline
  • GlySure
  • Goodman
  • Granular IT 
  • Gregory Fryer Associates
  • Harlan Laboratories
  • Harrison Clinical Research
  • Harwell Oxford
  • Health Protection Agency
  • Health Science Scotland
  • HealthTIES
  • Heptares Therapeutics
  • HGF, Patent & Trademark Attorneys
  • High Commission of Canada
  • High Force Research
  • HMA Digital Marketing
  • Horizon Discovery
  • Horton Ruston Poole
  • Horus Security
  • Hospira Inc. (US)   
  • Incanthera
  • immatics biotechnologies GmbH (Germany)
  • Immunocore 
  • ImmunNovative Developments (Spain)
  • ImmuPharma plc
  • Imperial Innovations
  • INC Research
  • Index Ventures
  • InhibOx
  • Innovaro Pharmalicensing
  • Inocul8
  • InSphero AG (Switzerland)
  • Interea International
  • Intertek Pharmaceutical Services
  • InteSpring B.V. (Netherlands)
  • Inventages
  • IP Asset Ventures
  • IP Group plc
  • Isis Innovation
  • Isogenica
  • ITC (Ukraine)
  • J&J Development Corporation (USA)
  • J A Kemp
  • James Cowper LLP
  • JP Morgan Asset Management
  • JPT Peptide Technologies GmbH (Germany)   
  • JSW Lifesciences Zagreb d.o.o. (Croatia)
  • Karolinksa Development AB (Sweden)
  • Karus Therapeutics
  • Kymab
  • Kelly Scientific Resources
  • Kilburn & Strode LLP
  • KLS-Partners (France)
  • K-MAC (South Korea)
  • Kuecept
  • KWS BioTest
  • Lab Support
  • Life Sciences Scotland
  • Liftstream
  • Locate in Kent
  • London Pharma
  • Ludger
  • Lundbeckfond Ventures
  • M+W Group
  • Malvern Therapeutics
  • Manches LLP
  • Mann Bioinvest 
  • Mathews Commercialisation Management
  • Mathys & Squire LLP
  • Matos Pharma (Japan)
  • MedImmune Ventures (USA)
  • Medifruit (Australia)   
  • Mediwatch plc
  • MedNous
  • Meeson Williams
  • MENARINI I.F.R. (Italy)
  • MEPC Granta Park
  • MEPC Milton Park
  • Mercia Fund Management
  • Merck & Co., Inc. (US)
  • Merck Research Ventures Fund (USA)
  • Merck Serono Ventures (Switzerland)
  • Mercury Pharma
  • Meridian Life Science, Inc. (US)
  • Merrill Corporation (US)
  • Merrill DataSite (US)
  • Mettler-Toledo
  • MGB Biopharma
  • Microvisk
  • Midven Venture
  • MinervaX (Denmark)
  • MISSION Therapeutics
  • Molecular Profiles
  • Momentum Bioscience
  • Morgan, Lewis and Bockius
  • Morrison & Foerster (UK) LLP
  • MorphoSys AG (Germany)
  • m2p-Labs (Germany)
  • MSD
  • Mucosis BV (Netherlands)
  • MVM Life Science Partners LLP
  • NeoMed (Switzerland)
  • New Hill Management
  • Nextech Invest (Switzerland)
  • Nature Biotech
  • Nature Publishing Group (US)    
  • NextGen Sciences (US)
  • NICE
  • Nightingale Associates
  • NIHR Biomedical Research Centre - Oxford & University of Oxford Medical Sciences Division
  • Ningbo HEALTH Gene Technologies (China)
  • Nomura Code
  • Norman Broadbent plc
  • Nortons India
  • Nottingham Trent University
  • NOTOX B.V. (Netherlands)
  • Novartis Pharmaceuticals (USA)
  • Novo A/S (Denmark)
  • Novozymes Biopharma UK 
  • Noxxon Pharma AG (Germany)
  • OBN
  • OctoPlus (Netherlands)
  • Office of Health Economics
  • Ontario Ministry of Economic Development and Trade (Canada)
  • ORION Clinical Services
  • Orthox
  • Osborne Clarke
  • Oval Medical Technologies
  • Oxford Biomaterials 
  • Oxford BioMedica plc
  • Oxford BioTherapeutics
  • Oxford Brookes University
  • Oxford Capital Partners
  • Oxford Gene Technology 
  • Oxford Innovation 
  • Oxford Medical Diagnostics
  • Oxford Pharmascience Group plc
  • Oxford Science Park
  • Oxford Technology Management
  • Oxford University Hospitals NHS Trust
  • Oxford University and the Oxford NIHR Biomedical Research Centre
  • Oxtex 
  • Pannone LLP
  • Partner International Inc. (Canada)
  • Patheon
  • Paul Capital
  • PBL
  • Penn Pharma
  • Peptisyntha
  • Pera Innovation   
  • Pfizer
  • Phase4 Ventures
  • PharmaDeals
  • pharmaphorum
  • PharmaVentures
  • Pharm-Analyt Lab. GmbH (Austria)
  • Pharminox    
  • Physiomics plc
  • PiR Limited
  • Piramal Discovery Solutions (Formerly O2h))
  • Piramal Healthcare
  • PlaqueTec Ltd
  • Plastic Antibodies Ltd
  • Ploughshare Innovations
  • Plexus Ventures
  • PolyTherics Ltd
  • Potter Clarkson LLP
  • Private Investors
  • Procarta Biosystems
  • Progenitor Labs Limited
  • Progressive Digital Media
  • ProImmune
  • Promega UK
  • ProRetina Therapeutics (Spain)
  • Prosonix
  • Protaffin AG (Austria)
  • Proteros Biostructures GmbH (Germany)
  • Providion
  • PsiOxus Therapeutics Ltd
  • QED Clinical Services Ltd
  • QPS
  • QRC Consultants
  • Quality Assistance (Belgium)
  • Quay Pharmaceuticals
  • Queen Mary University of London
  • Quest Diagnostics Clinical Trials
  • QuickSTAT
  • Quotient Bioresearch
  • Rainbow Seed Fund
  • Reading Scientific Services Ltd
  • Reckitt Benckiser
  • Redx Pharma Ltd
  • Reed Scientific
  • Regenesance B.V. (Netherlands)
  • ReGen Therapeutics
  • Rethink Orthopedics Ltd
  • Ricerca Biosciences
  • Riverbank IT Management
  • Royal Society Enterprise Fund   
  • RRG Consultancy
  • RSA
  • Russlan Clinical Research (Isle of Man)
  • Saretius
  • Safeguard Biosystems
  • Santaris Pharma A/S (Denmark)
  • Saturn Biosciences
  • Scancell Holdings plc
  • Science to Market Venture Capital GmbH (Germany)
  • Scientific Lesser 
  • Scrip Intelligence (media)
  • Scottish Development International
  • Scottish Enterprise
  • SeaLife Pharma GmbH (Austria)
  • Selcia Limited
  • Selventa Inc. (US)
  • Sera Laboratories International Limited
  • Seroba Kernel Life Sciences (Ireland)
  • Seventure Partners (France)
  • SGS M-Scan
  • Shire
  • Shire Strategic Investment Group (USA)
  • Sigma-Aldrich
  • Silicon Valley Bank
  • Simbec Research Limited
  • Sirakoss
  • SmartSensor Telemed
  • Singer Capital Markets
  • Sofinnova Partners (France)
  • SoftCell Medical
  • Source BioScience
  • SPARK Impact 
  • SPARK Ventures (France)
  • Sphere Fluidics 
  • SR One 
  • SRG
  • Stratagem IPM 
  • Summit plc
  • State of Georgia USA
  • SV Life Sciences
  • Sudbrook Associates
  • Symbiosis Pharmaceutical Services
  • Synergy Outsourcing
  • Sygnature Discovery 
  • Syne qua non 
  • Synergis Technologies
  • Syntaxin
  • Syntecnos (Netherlands)
  • Takeda Pharmaceuticals 
  • Takeda UK Ltd
  • Talentmark
  • TCD Pharma (Spain)
  • Team Ventures
  • Technology Strategy Board
  • Teijin Pharma 
  • Teva Pharmaceutical Industries (Israel)
  • The Babraham Institute
  • The Electrospinning Company
  • The FSE Group
  • The Communications Strategy Group Inc. (USA)
  • The London Clinic
  • Theorem Clinical Research
  • Thermo Fisher Scienitific
  • The Pink Sheet
  • The University of Liverpool
  • The Wellcome Trust
  • Theobald Associates
  • Tillotts Pharma AG (Switzerland)
  • Tokai Pharmaceuticals (US)
  • Torreya Partners
  • TPG Capital LLP
  • TranScrip Partners
  • Trifermed (Spain)
  • Total Scientific 
  • Tutela Monitoring Systems
  • Ubichem Pharma Services
  • UK Lifescience Industry Magazine
  • UCL
  • UK Bioincubator Forum
  • UKTI
  • UKTI Investment Services
  • UMIP
  • Unicorn Biologics Limited
  • United Plastics Group Inc
  • University College London
  • University of Bradford
  • University of Cambridge
  • University of Dundee
  • University of Leicester - Enterprise & Business Development
  • University of Oxford
  • Vectura plc
  • Venture Market Intelligence
  • Venture Valuation (Switzerland)
  • Ventac Partners (Spain)
  • Vernalis 
  • Vertex Pharmaceuticals (Europe) 
  • VHsquared Limited
  • Videregen
  • Vitrology
  • Vivacta
  • Vivotecnia (Spain)
  • Warwick Ventures Limited
  • Wellington Partners (Germany)
  • Western Provident Association
  • WIL Research (Netherlands)
  • WilmerHale
  • Wolfram Research
  • World Courier
  • WuXi Apptec
  • Xiber Science GmbH (Austria)
  • Ysios Capital Partners (Spain)